Abstract:Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common and serious postoperative complication of cardiac surgery requiring cardiopulmonary bypass (CPB), and it is the second most common cause of AKI in the intensive care unit. Although the complication has been associated with the use of CPB, the etiology is likely multifactorial and related to intraoperative and early postoperative management including pharmacologic therapy. To date, very little evidence from randomized trials supporting specifi… Show more
“…Notably, in spite of the pharmacological interventions for CSA-AKI including the use of natriuretic peptides and dopamine agonists, there has been no clearly defined medicine for the treatment of this disorder [3]. In particular, a multisite trial in Japan showed that atrial natriuretic peptide did not significantly improve renal function in cardiac surgery patients with AKI [36].…”
Section: Discussionmentioning
confidence: 99%
“…CSA-AKI is caused by multiple factors, which involve different injury pathways including metabolic abnormalities, ischemia and reperfusion injury, neurohormonal activation, inflammation, and oxidative stress [2]. Due to the differences in baseline characteristics and surgery types, studies of the epidemiology of CSA-AKI in recent years showed the range of CSA-AKI incidence is between 8.9 and 39% [3]. Renal impairment during cardiac surgery is often associated with renal hypoperfusion caused by the bleeding complications [4], while exposure of blood to the cardiopulmonary bypass (CPB) pump and circuit often activate different inflammatory pathways [5].…”
Background/Aims: Cardiac surgery-associated acute kidney injury (CSA-AKI) is one of the most common postoperative complications in intensive care medicine. Baicalin has been shown to have anti-inflammatory and antioxidant roles in various disorders. We aimed to test the protective effects of baicalin on CSA-AKI using a rat model. Methods: Sprague-Dawley rats underwent 75 min of cardiopulmonary bypass (CPB) with 45 min of cardioplegic arrest (CA) to establish the AKI model. Baicalin was administered at different doses intragastrically 1 h before CPB. The control and treated rats were subjected to the evaluation of different kidney injury index and inflammation biomarkers. Results: Baicalin significantly attenuated CPB/CA-induced AKI in rats, as evidenced by the lower levels of serum creatinine, serum NGAL, and Kim1. Baicalin remarkably inhibited oxidative stress, reflected in the decreased malondialdehyde and myeloperoxidase activity, and enhanced superoxide dismutase activity and glutathione in renal tissue. Baicalin suppressed the expression of IL-18 and iNOS, and activated the Nrf2/HO-1 pathway. Conclusion: Our data indicated that baicalin mediated CPB/CA-induced AKI by decreasing the oxidative stress and inflammation in the renal tissues, and that baicalin possesses the potential to be developed as a therapeutic tool in clinical use for CSA-AKI.
“…Notably, in spite of the pharmacological interventions for CSA-AKI including the use of natriuretic peptides and dopamine agonists, there has been no clearly defined medicine for the treatment of this disorder [3]. In particular, a multisite trial in Japan showed that atrial natriuretic peptide did not significantly improve renal function in cardiac surgery patients with AKI [36].…”
Section: Discussionmentioning
confidence: 99%
“…CSA-AKI is caused by multiple factors, which involve different injury pathways including metabolic abnormalities, ischemia and reperfusion injury, neurohormonal activation, inflammation, and oxidative stress [2]. Due to the differences in baseline characteristics and surgery types, studies of the epidemiology of CSA-AKI in recent years showed the range of CSA-AKI incidence is between 8.9 and 39% [3]. Renal impairment during cardiac surgery is often associated with renal hypoperfusion caused by the bleeding complications [4], while exposure of blood to the cardiopulmonary bypass (CPB) pump and circuit often activate different inflammatory pathways [5].…”
Background/Aims: Cardiac surgery-associated acute kidney injury (CSA-AKI) is one of the most common postoperative complications in intensive care medicine. Baicalin has been shown to have anti-inflammatory and antioxidant roles in various disorders. We aimed to test the protective effects of baicalin on CSA-AKI using a rat model. Methods: Sprague-Dawley rats underwent 75 min of cardiopulmonary bypass (CPB) with 45 min of cardioplegic arrest (CA) to establish the AKI model. Baicalin was administered at different doses intragastrically 1 h before CPB. The control and treated rats were subjected to the evaluation of different kidney injury index and inflammation biomarkers. Results: Baicalin significantly attenuated CPB/CA-induced AKI in rats, as evidenced by the lower levels of serum creatinine, serum NGAL, and Kim1. Baicalin remarkably inhibited oxidative stress, reflected in the decreased malondialdehyde and myeloperoxidase activity, and enhanced superoxide dismutase activity and glutathione in renal tissue. Baicalin suppressed the expression of IL-18 and iNOS, and activated the Nrf2/HO-1 pathway. Conclusion: Our data indicated that baicalin mediated CPB/CA-induced AKI by decreasing the oxidative stress and inflammation in the renal tissues, and that baicalin possesses the potential to be developed as a therapeutic tool in clinical use for CSA-AKI.
“…Based on these findings, it can be stated that the preoperative and operative periods are important for AKI development, but the use of classical markers such as SCr levels to diagnose AKI can cause a delay in the diagnosis. To prevent CABG-related AKI, three predictive risk scores based on preoperative variables have been developed: the Cleveland Clinic Score, the Mehta Score and the Simplified Renal Index Score [7]. However, there has been no consensus among authors with regard to recommending the use of a specific score to predict AKI before CABG.…”
Section: Discussionmentioning
confidence: 99%
“…As a result of chronic inflammatory processes, atherosclerosis might affect both coronary and renal arteries. In this context, coronary artery disease was found to be closely associated with AKI [7]. …”
Section: Introductionmentioning
confidence: 99%
“…However, the optimal time at which to use NGAL for detecting AKI due to renal parenchyma damage is still unknown and needs further research. Also, the relationship between NGAL and those factors causing renal parenchymal damage during the preoperative and postoperative periods is very important while planning prophylactic treatment for possible acute renal failure [7]. …”
Introduction: Acute kidney injury (AKI) is an important complication of cardiac surgery due to its high mortality. The aim of the present study was to detect the factors leading to AKI in patients who underwent coronary artery bypass surgery (CABS) and also to determine the optimal timing for detecting AKI using the biomarker neutrophil gelatinase-associated lipocalin (NGAL). Materials and Methods: The records of 375 patients who underwent CABS were reviewed in this case-control study. Ejection fraction (EF), common carotid artery intima-media thickness (CCA-IMT) and cross-clamp (C-C) time of the patients were recorded. Blood samples were taken from all patients on preoperative day 1 as well as 6, 12, 24, 36, 48 h and 7 days after operation. Biochemical parameters were studied in patients with and without AKI. Results: According to the Risk Injury Failure Loss End Stage criteria, 24 patients had renal risk, 17 had injury and 4 had failure. Postoperative 24-hour serum creatinine levels indicated the risk of renal dysfunction for only 4 patients in the AKI group. CCA-IMT, C-C time, haematocrit (HCT) and preoperative interleukin-6 levels were significantly higher in the AKI group than in the non-AKI group. Postoperative 6- and 12-hour NGAL levels in the AKI group correlated with postoperative 36-hour serum creatinine levels. The optimal cut-off values for postoperative 6- and 12-hour NGAL test were 310 and 283 ng/ml, respectively. The area under the curve was higher in the 12-hour NGAL test (p < 0.0086). Conclusion: The number of stenotic coronary arteries, EF, CCA-IMT and HCT are all important risk factors. Early postoperative NGAL results were highly specific for the early recognition of AKI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.